TCL Archive Congress Signals Willingness to Break With Administration on NIH Funding. March 24, 2006Vol.32 No.11
TCL Archive Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named. March 24, 2006Vol.32 No.11
TCL Archive ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer. March 24, 2006Vol.32 No.11
TCL Archive Bush Nominates von Eschenbach For FDA; Democrats Put Hold On Confirmation. von Eschenbach To Step Down As NCI Director, But Details Unavailable; No Acting Director Named. Applause, Outrage, Over Nomination. Now, von Eschenbach Leads A Retreat From 2015 Target Date For His Challenge Goal. March 17, 2006Vol.32 No.10
TCL Archive Obituary: Joseph Burchenal, 93, A Leader In Cancer Drug Development at MSKCC. March 17, 2006Vol.32 No.10
TCL Archive As von Eschenbach Prepares For New Assignment, NCI’s 2015 Goal Faces Uncertainty. New Strategic Plan Lists Steps to 2015. “The Vision Is Within Our Grasp,” von Eschenbach Says. March 10, 2006Vol.32 No.9
TCL Archive White House Preparing To Nominate Andrew von Eschenbach as FDA Commissioner, Sources Said March 03, 2006Vol.32 No.8
TCL Archive NCI Releases List of Cancer Center Core Grant Funding for FY 2005; Univ. of New Mexico is the Newest NCI-Designated Center. March 03, 2006Vol.32 No.8
